See more : VICI Properties Inc. (VICI) Income Statement Analysis – Financial Results
Complete financial analysis of Redcare Pharmacy NV (SHPPF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Redcare Pharmacy NV, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- Hakudo Co., Ltd. (7637.T) Income Statement Analysis – Financial Results
- Aimia Inc. (AIM.TO) Income Statement Analysis – Financial Results
- Shanghai Daimay Automotive Interior Co., Ltd (603730.SS) Income Statement Analysis – Financial Results
- Kimbell Royalty Partners, LP (KRP) Income Statement Analysis – Financial Results
- BMO ULTRA SHORT TERM US BOND ET (ZUSFF) Income Statement Analysis – Financial Results
Redcare Pharmacy NV (SHPPF)
About Redcare Pharmacy NV
Redcare Pharmacy NV owns and operates online pharmacies in Germany, Austria, Switzerland, France, Belgium, Italy, and the Netherlands. It provides prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products, as well as food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. The company was founded in 2001 and is headquartered in Sevenum, the Netherlands.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.80B | 1.20B | 1.06B | 968.06M | 701.01M | 539.71M | 283.99M | 177.39M | 125.58M | 84.67M | 55.29M |
| Cost of Revenue | 1.36B | 872.57M | 793.79M | 748.53M | 563.33M | 440.39M | 226.41M | 141.11M | 99.84M | 66.64M | 42.55M |
| Gross Profit | 440.38M | 331.79M | 266.53M | 219.53M | 137.68M | 99.32M | 57.58M | 36.28M | 25.74M | 18.04M | 12.75M |
| Gross Profit Ratio | 24.48% | 27.55% | 25.14% | 22.68% | 19.64% | 18.40% | 20.28% | 20.45% | 20.49% | 21.30% | 23.05% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 33.00M | 26.51M | 21.25M | 19.39M | 15.51M | 13.79M | 8.98M | 4.61M | 4.14M | 1.92M | 1.24M |
| Selling & Marketing | 234.44M | 217.73M | 175.63M | 125.85M | 93.20M | 64.71M | 46.66M | 28.69M | 20.89M | 13.07M | 8.36M |
| SG&A | 267.44M | 244.24M | 196.88M | 145.24M | 108.71M | 78.50M | 55.64M | 33.30M | 25.03M | 15.00M | 9.59M |
| Other Expenses | 190.24M | 0.00 | 0.00 | 65.00K | 136.00K | -4.00K | 3.02M | 2.20M | 1.32M | 928.00K | 673.00K |
| Operating Expenses | 457.68M | 401.11M | 332.39M | 220.46M | 171.86M | 128.24M | 79.80M | 50.13M | 35.87M | 23.01M | 15.30M |
| Cost & Expenses | 1.82B | 1.27B | 1.13B | 968.99M | 735.19M | 568.64M | 306.20M | 191.23M | 135.71M | 89.65M | 57.84M |
| Interest Income | 4.61M | 274.00K | 28.00K | 93.00K | 112.00K | 24.00K | 40.00K | 17.00K | 593.00K | 0.00 | 0.00 |
| Interest Expense | 8.00M | 8.50M | 8.57M | 10.76M | 7.48M | 3.44M | 2.25M | 9.34M | 2.28M | 826.00K | 839.00K |
| Depreciation & Amortization | 57.29M | 39.51M | 26.96M | 16.06M | 7.86M | 7.43M | 3.63M | 864.00K | 2.17M | 1.66M | 1.13M |
| EBITDA | 50.94M | -33.23M | -42.35M | 10.89M | -19.83M | -17.98M | -15.56M | -10.78M | -6.06M | -2.39M | -752.00K |
| EBITDA Ratio | 2.83% | -2.76% | -3.99% | 1.16% | -2.91% | -3.33% | -4.26% | -4.71% | -4.83% | -2.83% | -1.36% |
| Operating Income | -17.30M | -69.17M | -65.70M | -866.00K | -33.45M | -28.73M | -19.20M | -11.64M | -8.82M | -4.05M | -1.88M |
| Operating Income Ratio | -0.96% | -5.74% | -6.20% | -0.09% | -4.77% | -5.32% | -6.76% | -6.56% | -7.02% | -4.78% | -3.40% |
| Total Other Income/Expenses | 2.95M | -14.95M | -12.19M | -15.07M | -8.74M | -5.86M | -2.21M | -9.32M | -1.68M | -826.00K | -839.00K |
| Income Before Tax | -14.35M | -84.12M | -77.88M | -15.93M | -42.18M | -34.59M | -21.40M | -20.96M | -10.50M | -4.87M | -2.72M |
| Income Before Tax Ratio | -0.80% | -6.98% | -7.35% | -1.65% | -6.02% | -6.41% | -7.54% | -11.82% | -8.36% | -5.76% | -4.91% |
| Income Tax Expense | -2.74M | -6.47M | -3.70M | 839.00K | -5.91M | -982.00K | -45.00K | -2.52M | 47.00K | 161.00K | 113.00K |
| Net Income | -12.04M | -77.65M | -74.19M | -16.77M | -36.27M | -33.61M | -21.36M | -18.45M | -10.55M | -5.04M | -2.83M |
| Net Income Ratio | -0.67% | -6.45% | -7.00% | -1.73% | -5.17% | -6.23% | -7.52% | -10.40% | -8.40% | -5.95% | -5.12% |
| EPS | -0.63 | -4.32 | -4.15 | -1.17 | -2.78 | -2.79 | -2.25 | -2.03 | -1.16 | -0.56 | -0.31 |
| EPS Diluted | -0.63 | -4.32 | -4.15 | -1.17 | -2.78 | -2.79 | -2.25 | -2.03 | -1.16 | -0.56 | -0.31 |
| Weighted Avg Shares Out | 19.24M | 17.98M | 17.88M | 14.38M | 13.06M | 12.05M | 9.50M | 9.07M | 9.07M | 9.07M | 9.07M |
| Weighted Avg Shares Out (Dil) | 19.24M | 17.98M | 17.88M | 14.38M | 13.06M | 12.05M | 9.50M | 9.07M | 9.07M | 9.07M | 9.07M |
CTP Builds 30,000 sqm of Distribution Space for Redcare Pharmacy, Europe's Leading Online Pharmacy
Redcare Pharmacy NV (SAEYY) Q3 2024 Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports